Juan Gómez Rivas, Associate Professor at Complutense University of Madrid, shared on X:
“Uro-oncology is multidisciplinary.
Great to be part of EMUC26, sharing perspectives and learning from colleagues across different specialties.
The management of urological cancers is evolving rapidly, with advances in imaging, molecular profiling, systemic therapies, and surgical approaches reshaping clinical practice.
But innovation alone is not enough. The real challenge is integrating these advances into personalized, evidence-based, and patient-centered care.
True multidisciplinarity goes beyond tumor boards. It means challenging perspectives, sharing expertise, and making better decisions together.”
You can also read:
Felipe Couñago: Prostate Cancer Screening and Early Detection Take Center Stage at EMUC26
